Oxytocin and vaginal dinoprostone in labor induction: A systematic review and meta-analysis.
cesarean delivery
induction of labor
oxytocin
prostaglandin E2
vaginal delivery
Journal
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
ISSN: 1879-3479
Titre abrégé: Int J Gynaecol Obstet
Pays: United States
ID NLM: 0210174
Informations de publication
Date de publication:
25 Feb 2024
25 Feb 2024
Historique:
revised:
02
02
2024
received:
04
10
2023
accepted:
07
02
2024
medline:
26
2
2024
pubmed:
26
2
2024
entrez:
26
2
2024
Statut:
aheadofprint
Résumé
The comparison between prostaglandin E2 (PGE2) and oxytocin and for induction of labor (IOL) remains controversial. The present study aimed to determine the safety and efficacy of these two agents in IOL. PubMed, Embase, Web of Science, Cochrane Library, and ClinicalTrials.gov. from the establishment of the database to April 23, 2023. A search was conducted with keywords "labor, induction, prostaglandin E2/PGE2/dinoprostone, and oxytocin". Only randomized clinical trials comparing oxytocin and vaginal dinoprostone in women who were at least late preterm (gestational age [GA] ≥34 weeks), singleton pregnant, and had intact membranes were enrolled for further meta-analysis. We conducted both a descriptive analysis and a meta-analysis. In the meta-analysis, we utilized the Mantel-Haenszel random effects model to analyze dichotomous data, employing the relative risk (RR) as the effect measure along with 95% confidence intervals (CIs). The study quality was evaluated using Cochrane Collaboration's risk of bias assessment tool (RoB 2). A random-effects model was applied for the meta-analysis. After screening 3303 articles from five databases, a total of nine randomized controlled studies composed of 1071 patients were included. Our analysis included 534 patients in the PGE2 group and 537 patients in the oxytocin group. The pooled estimate of vaginal deliveries following PGE2 induction stood at 84.2%, while after oxytocin induction, it was 79.8%. The meta-analysis showed no statistical difference between the two groups in terms of the rate of vaginal delivery (pooled RR, 1.05; 95% CI: 0.95-1.16; P value for Q, 0.001; I When amalgamating the available literature, it implies that oxytocin was found to have similar effects as PGE2 on delivery outcomes and safety concerns in pregnant women with GA ≥36 weeks. Although the uterine cervix was unfavorable, both low and high doses of oxytocin were feasible for IOL.
Sections du résumé
BACKGROUND
BACKGROUND
The comparison between prostaglandin E2 (PGE2) and oxytocin and for induction of labor (IOL) remains controversial.
OBJECTIVE
OBJECTIVE
The present study aimed to determine the safety and efficacy of these two agents in IOL.
SEARCH STRATEGY
METHODS
PubMed, Embase, Web of Science, Cochrane Library, and ClinicalTrials.gov. from the establishment of the database to April 23, 2023.
SELECTION CRITERIA
METHODS
A search was conducted with keywords "labor, induction, prostaglandin E2/PGE2/dinoprostone, and oxytocin". Only randomized clinical trials comparing oxytocin and vaginal dinoprostone in women who were at least late preterm (gestational age [GA] ≥34 weeks), singleton pregnant, and had intact membranes were enrolled for further meta-analysis.
DATA COLLECTION AND ANALYSIS
METHODS
We conducted both a descriptive analysis and a meta-analysis. In the meta-analysis, we utilized the Mantel-Haenszel random effects model to analyze dichotomous data, employing the relative risk (RR) as the effect measure along with 95% confidence intervals (CIs). The study quality was evaluated using Cochrane Collaboration's risk of bias assessment tool (RoB 2). A random-effects model was applied for the meta-analysis.
MAIN RESULTS
RESULTS
After screening 3303 articles from five databases, a total of nine randomized controlled studies composed of 1071 patients were included. Our analysis included 534 patients in the PGE2 group and 537 patients in the oxytocin group. The pooled estimate of vaginal deliveries following PGE2 induction stood at 84.2%, while after oxytocin induction, it was 79.8%. The meta-analysis showed no statistical difference between the two groups in terms of the rate of vaginal delivery (pooled RR, 1.05; 95% CI: 0.95-1.16; P value for Q, 0.001; I
CONCLUSIONS
CONCLUSIONS
When amalgamating the available literature, it implies that oxytocin was found to have similar effects as PGE2 on delivery outcomes and safety concerns in pregnant women with GA ≥36 weeks. Although the uterine cervix was unfavorable, both low and high doses of oxytocin were feasible for IOL.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 International Federation of Gynecology and Obstetrics.
Références
Tsakiridis I, Mamopoulos A, Athanasiadis A, Dagklis T. Induction of labor: an overview of guidelines. Obstet Gynecol Surv. 2020;75(1):61-72.
De Berti M, Le Gouge A, Monmousseau F, et al. Oxytocin versus prostaglandins for labour induction of women with an unfavourable cervix after 24 hours of cervical ripening (OPIC): protocol for an open multicentre randomised non-inferiority trial. BMJ Open. 2023;13(4):e058282.
Kehl S, Hösli I, Pecks U, et al. Induction of labour. Guideline of the DGGG, OEGGG and SGGG (S2k, AWMF registry no. 015-088, December 2020). Geburtshilfe Frauenheilkd. 2021;81(8):870-895.
de Vaan MD, Ten Eikelder ML, Jozwiak M, et al. Mechanical methods for induction of labour. Cochrane Database Syst Rev. 2019;10(10):CD001233.
Walter MH, Abele H, Plappert CF. The role of oxytocin and the effect of stress during childbirth: neurobiological basics and implications for mother and child. Front Endocrinol. 2021;12:742236.
Budden A, Chen LJY, Henry A. High-dose versus low-dose oxytocin infusion regimens for induction of labour at term. Cochrane Database Syst Rev. 2014;2014(10):CD009701.
Vince K, Matijević R. Comparison of intracervical and intravaginal prostaglandin E2 for induction of labor in term pregnancies with unfavorable cervix: randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2022;270:100-104.
Thomas J, Fairclough A, Kavanagh J, Kelly AJ. Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database Syst Rev. 2014;6:CD003101.
Ting NS, Ding DC, Wei YC. Comparison of the Dinoprostone vaginal insert and dinoprostone tablet for the induction of labor in primipara: a retrospective cohort study. J Clin Med Res. 2022;11(12):3519.
Tseng JY, Lin IC, Chang WH, Yeh CC, Horng HC, Wang PH. Using dinoprostone vaginal insert for induction of labor: a single institute experience. Taiwan J Obstet Gynecol. 2020;59(5):723-727.
Kalkat RK, McMillan E, Cooper H, Palmer K. Comparison of dinoprostone slow release pessary (Propess) with gel (Prostin) for induction of labour at term-a randomised trial. J Obstet Gynaecol. 2008;28(7):695-699.
Marconi AM. Recent advances in the induction of labor. F1000Res. 2019;8:1829. doi:10.12688/f1000research.17587.1
Hung CH, Chen HY, Kang J, Tai YY, Lin SY, Lee CN. Propess versus prostin for induction of labour in term primiparous women. J Formos Med Assoc. 2023;122(8):785-789.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
Jackson JL, Kuriyama A, Anton A, et al. The accuracy of Google translate for abstracting data from non-English-language trials for systematic reviews. Ann Intern Med. 2019;171(9):677-679.
American College of Obstetricians and Gynecologists' Committee on Obstetric Practice, Society for Maternal-Fetal Medicine. Medically indicated late-preterm and early-term deliveries: ACOG Committee opinion, number 831. Obstet Gynecol. 2021;138(1):e35-e39.
Overview | Twin and triplet pregnancy | Guidance | NICE. Accessed May 29, 2023. www.nice.org.uk/guidance/ng137
Devillard E, Delabaere A, Rouzaire M, et al. Induction of labour in case of premature rupture of membranes at term with an unfavourable cervix: protocol for a randomised controlled trial comparing double balloon catheter (+oxytocin) and vaginal prostaglandin (RUBAPRO) treatments. BMJ Open. 2019;9(6):e026090.
Ghafoor S. Current and emerging strategies for prediction and diagnosis of prelabour rupture of the membranes: a narrative review. Malays J Med Sci. 2021;28(3):5-17.
Gravett C, Eckert LO, Gravett MG, et al. Non-reassuring fetal status: case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2016;34(49):6084-6092.
ACOG Practice Bulletin No. 106: intrapartum fetal heart rate monitoring: nomenclature, interpretation, and general management principles. Obstet Gynecol. 2009;114(1):192-202.
Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.
Higgins JPT, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions. John Wiley & Sons; 2019.
Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.
Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455-463.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634.
Chi CC, Shao SC, Kuo LT, Huang YT, Lai PC. Using grading of recommendations assessment, development, and evaluation (GRADE) to rate the certainty of evidence of study outcomes from systematic reviews: a quick tutorial. Dermatol Sin. 2023;41(1):3.
Chen W, Zhou Y, Pu X, Xiao C. Evaluation of propess outcomes for cervical ripening and induction of labour in full-term pregnancy. J Obstet Gynaecol. 2014;34(3):255-258.
Koc O, Duran B, Ozdemirci S, Albayrak M, Koc U. Oxytocin versus sustained-release dinoprostone vaginal pessary for labor induction of unfavorable cervix with Bishop score ≥4 and ≤6: A randomized controlled trial. J Obstet Gynaecol Res. 2013;39(4):790-798.
Akay NÖ, Hızlı D, Yılmaz SS, Yalvaç S, Kandemir O. Comparison of low-dose oxytocin and dinoprostone for labor induction in postterm pregnancies: a randomized controlled prospective study. Gynecol Obstet Investig. 2012;73(3):242-247.
Parazzini F, Benedetto C, Danti L, et al. A randomized comparison of vaginal prostaglandin E2 with oxytocin plus amniotomy for induction of labour in women with intermediately ripe cervices. Eur J Obstet Gynecol Reprod Biol. 1998;81(1):15-20.
Taylor AVG, Sellers S, Ah-moye M, Mackenzie IZ. A prospective random allocation trial to compare vaginal prostaglandin E2 with intravenous oxytocin for labour induction in women previously delivered by caesarean section. J Obstet Gynaecol. 1993;13(5):333-336.
Lyndrup J, Legarth J, Dahl C, Philipsen T, Eriksen PS, Weber T. Induction of labour: the effect of vaginal prostaglandin or i.v. oxytocin - a matter of time only? Eur J Obstet Gynecol Reprod Biol. 1990;37(2):111-119.
Silva-Cruz A, Godinho F, Pinto JM, Andrade L, Simões D. Prostaglandin E2 gel compared to oxytocin for medically-indicated labour induction at term: a controlled clinical trial. Pharmatherapeutica. 1988;5(4):228-232.
Legarth J, Lyndrup J, Dahl C, Philipsen T, Eriksen PS. Prostaglandin E2 vaginal suppository for induction of labour: an efficient, safe and popular method. Eur J Obstet Gynecol Reprod Biol. 1987;26(3):233-238.
Kennedy JH, Stewart P, Barlow DH, Hillan E, Calder AA. Induction of labour: a comparison of a single prostaglandin E2 vaginal tablet with amniotomy and intravenous oxytocin. Br J Obstet Gynaecol. 1982;89(9):704-707.
Zhao L, Lin Y, Jiang T, et al. Prediction of the induction to delivery time interval in vaginal dinoprostone-induced labor: a retrospective study in a Chinese tertiary maternity hospital. J Int Med Res. 2019;47(6):2647-2654.
Alfirevic Z, Kelly AJ, Dowswell T. Intravenous oxytocin alone for cervical ripening and induction of labour. Cochrane Database Syst Rev. 2009;2009(4):CD003246.
Akobeng AK. Understanding type I and type II errors, statistical power and sample size. Acta Paediatr. 2016;105(6):605-609.
Overview | Inducing labour | Guidance | NICE. Accessed September 9, 2023. http://www.nice.org.uk/guidance/ng207
Arias F. Pharmacology of oxytocin and prostaglandins. Clin Obstet Gynecol. 2000;43(3):455-468.
Carlson N, Ellis J, Page K, Dunn Amore A, Phillippi J. Review of evidence-based methods for successful labor induction. J Midwifery Womens Health. 2021;66(4):459-469.